CSIMarket
 


Cardiff Oncology inc   (CRDF)
Other Ticker:  
 
 

Cardiff Oncology Inc Accounts Receivables Turnover Ratio from the third quarter 2023 to the third quarter 2022

Quarterly Results, Trends, Rankings, Statistics


Cardiff Oncology Inc 's ability to collect its outstanding accounts receivable from its corporate clients, has improved in the third quarter 2023 to a ratio of 6.57, this represents a new company high. This is a clear indication for improving liquidity at Cardiff Oncology Inc 's clients. Average receivable collection period, for the Cardiff Oncology Inc in Sep 30 2023 quarter, has decreased to 56 days, compared to 89 days, in the Jun 30 2023 quarter.

If we take a look into Healthcare sector 240 other companies have achieved higher receivables turnover ratio. While receivables turnover ratio total ranking has improved thus far to 1753, from overall ranking in the second quarter 2023 at 4179.

What is Receivable Turnover Ratio?
What is Cardiff Oncology Inc Selling?


What is Receivable Turnover Ratio?




CRDF Receivables Turnover Ratio (Sep 30 2023)
III. Quarter
(Jun 30 2023)
II. Quarter
(Mar 31 2023)
I. Quarter
(Dec 31 2022)
IV. Quarter
(Sep 30 2022)
III. Quarter
Y / Y Receivable Change -69.54 % -70.78 % 51.23 % 44.11 % 64.56 %
Y / Y Revenue Change 119.42 % 237.5 % 401.47 % - 540.7 %
Receivable Turnover Ratio (TTM) 6.57 4.09 2.26 1.11 2.78
CRDF's Total Ranking # 1753 # 4179 # 2692 # 4187 # 3420
Average receivable collection period 56 89 162 327 131
Seq. Receivable Change 22.98 % -76.18 % -12.32 % 18.62 % 17.97 %
Seq. Revenue Change 4.13 % 13.49 % - - 60.17 %


Receivable Turnover Company Ranking
Within: No.
Biotechnology & Pharmaceuticals Industry # 27
Healthcare Sector # 241
Overall Market # 1753

Receivable Turnover Ratio Statistics
High Average Low
6.57 3.02 0.38
(Sep 30 2023)   (Jun 30 2020)






Financial Statements
Cardiff Oncology Inc 's Accounts Receivable $ 0 Millions Visit CRDF's Balance sheet
Cardiff Oncology Inc 's Sales TTM $ 3 Millions Visit CRDF's Income Statement
Where are CRDF's Sales coming from? Visit CRDF's Sales by Geography

Other Accounts Receivable Turnover Ratios
Biotechnology & Pharmaceuticals Industry Accounts Receivable Turnover Trends and Statistics
Healthcare Sector Accounts Receivable Turnover Statistics
Accounts Receivables Turnover Trends for overall market
CRDF's Receivable Turnover Ratio versus Biotechnology & Pharmaceuticals Industry, Healthcare Sector and total Market
Highest Ranking Accounts Receivables Turnover
Lowest Ranking Accounts Receivables Turnover
Accounts Receivable Turnover for CRDF's Competitors
Receivables Turnover Ratio for CRDF's Suppliers
Accounts Receivables Turnover Ratio for CRDF's Customers

You may also want to know
CRDF's Growth Rates CRDF's Roa CRDF's Inventory Turnover Ratio CRDF's Dividend Comparisons
CRDF's Profitability Ratios CRDF's Roi CRDF's Asset Turnover Ratio CRDF's Dividend Growth
CRDF's Valuation Ratios CRDF's Roe CRDF's Financial Strength Ratios CRDF's Dividend Payout Ratio



Companies with similar Receivables Turnover Ratio for the quarter ending Sep 30 2023, within Healthcare Sector Receivable Turnover Ratio Revenues for 12 Months ending Sep 30 2023 Receivable at quarter ending Sep 30 2023
Mei Pharma Inc   40.65 $ 105.383  Millions$ 2.592  Millions
Vbi Vaccines Inc  40.26 $ 8.122  Millions$ 0.202  Millions
Lineage Cell Therapeutics Inc   40.10 $ 8.772  Millions$ 0.219  Millions
Spero Therapeutics Inc   38.72 $ 77.699  Millions$ 2.007  Millions
Lifemd Inc   38.63 $ 133.842  Millions$ 3.465  Millions
Neptune Wellness Solutions Inc   38.14 $ 43.724  Millions$ 1.146  Millions
Nature s Sunshine Products inc   37.58 $ 437.245  Millions$ 11.635  Millions
Electrocore Inc   37.19 $ 13.399  Millions$ 0.360  Millions
Sonida Senior Living Inc   35.91 $ 249.127  Millions$ 6.938  Millions
Fusion Pharmaceuticals Inc   34.91 $ 2.208  Millions$ 0.063  Millions
China Pharma Holdings Inc   34.57 $ 7.783  Millions$ 0.225  Millions
23andme Holding Co  31.43 $ 269.726  Millions$ 8.583  Millions
Inmed Pharmaceuticals Inc   31.18 $ 5.287  Millions$ 0.170  Millions
Nektar Therapeutics  28.21 $ 88.260  Millions$ 3.129  Millions
Stoke Therapeutics Inc   28.20 $ 9.248  Millions$ 0.328  Millions
Eargo Inc   27.36 $ 39.694  Millions$ 1.451  Millions
National Vision Holdings Inc   26.49 $ 2,088.996  Millions$ 78.870  Millions
Capricor Therapeutics inc   25.66 $ 14.050  Millions$ 0.548  Millions
Voyager Therapeutics Inc   25.34 $ 158.398  Millions$ 6.250  Millions
Neuroone Medical Technologies Corporation  25.25 $ 1.952  Millions$ 0.077  Millions
Cue Health Inc   25.20 $ 198.915  Millions$ 7.894  Millions
Adaptimmune Therapeutics Plc  23.54 $ 75.969  Millions$ 3.227  Millions
Molecular Templates inc   23.22 $ 18.064  Millions$ 0.778  Millions
Qilian International Holding Group Limited  23.16 $ 45.751  Millions$ 1.976  Millions
Cv Sciences Inc   23.08 $ 15.578  Millions$ 0.675  Millions
C4 Therapeutics Inc   23.06 $ 20.349  Millions$ 0.882  Millions
Vaxart Inc   22.56 $ 4.156  Millions$ 0.184  Millions
Mymetics Corporation  21.62 $ 1.229  Millions$ 0.057  Millions
Ontrak Inc   21.60 $ 11.674  Millions$ 0.541  Millions
Pieris Pharmaceuticals Inc   21.38 $ 47.357  Millions$ 2.216  Millions

Date modified: 2023-11-03T13:45:20+00:00



Help

About us

Advertise

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2024 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com